Sign in

CIK 0001107421 · Non-accelerated filer<br>Smaller reporting company

Alaunos Therapeutics, Inc.

Sign in to watch
Ticker
TCRT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
841475642
Phone
(346) 355-4099
Business address
501 E LAS OLAS BLVD, SUITE 300, FORT LAUDERDALE, FL, 33301
Former names
ZIOPHARM ONCOLOGY INC, EASYWEB INC
  1. 4 Grant or award Director acquired 8,333 shares (grant or award)
  2. 4 Grant or award Director acquired 4,167 shares (grant or award)
  3. 4 Grant or award Director acquired 4,167 shares (grant or award)
  4. 3 Insider Initial Statement of Ownership
  5. 3 Insider Initial Statement of Ownership
  6. 3 Insider Initial Statement of Ownership
  7. 3 Insider Initial Statement of Ownership
  8. 4 Grant or award EVP, GM Gene Therapy acquired 31,500 shares (grant or award)
  9. 4 Grant or award Chief Legal Officer and Sec. acquired 43,500 shares (grant or award)
  10. 4 Grant or award Interim CEO acquired 90,000 shares (grant or award)
  11. 4 Grant or award EVP, GM Cell Therapy acquired 50,825 shares (grant or award)
  12. 3 Insider Initial Statement of Ownership
  13. 4 Open-market sale EVP, GM Gene Therapy sold 27,894 shares at $3.12 ($87,029)
  14. 4 Open-market sale SVP, Treasurer & CAO sold 18,020 shares at $3.09 ($55,682)
  15. 4 Open-market sale General Counsel and Secretary sold 26,500 shares at $3.12 ($82,680)
  16. 4 Open-market sale EVP, GM Cell Therapy sold 21,620 shares at $2.72 ($58,806)
  17. 4 Open-market sale President and CEO sold 105,693 shares at $2.71 ($286,428)
  18. 3 Insider Initial Statement of Ownership
  19. 4 Derivatives Options or other derivatives
  20. 3 Insider Initial Statement of Ownership

Page 6 of 24 · 465 filings